| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 117,992 | 102,290 | 121,085 | 157,965 | | Cost of Revenue | 90,909 | 88,694 | 101,810 | 128,194 | | | Gross Profit | 27,083 | 13,596 | 19,275 | 29,771 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,139 | 26,338 | 27,077 | 31,687 | | Non Recurring | 1,310 | 1,551 | 958 | 67,160 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,634 | (14,293) | (8,760) | (69,076) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 198 | (639) | (6) | 395 | | Earnings Before Interest And Taxes | (10,376) | (14,029) | (8,191) | (66,397) | | Interest Expense | (11,035) | 5,538 | 5,497 | 5,274 | | Income Before Tax | 659 | (19,567) | (13,688) | (71,671) | | Income Tax Expense | 1,502 | 197 | (2,108) | 36,723 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,021 | (19,764) | (11,580) | (108,394) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (843) | (19,764) | (11,580) | (108,394) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($843) | ($19,764) | ($11,580) | ($108,394) |
|
0.26% Nasdaq 
Income Statement
